ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 923,39
-0,77%
Dow Jones
37 903,29
0,23%
DAX
17 938,49
0,09%
Brent Oil
83,965
0,51%
Bitcoin
57 837,18
-0,69%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Cellectar Biosciences Inc (CLRB)

  7. Cellectar Biosciences Inc (CLRB) Actualités

CLRB Cellectar Biosciences Inc

3,20
0,04 (1,27%)
Avant marché
Dernière mise à jour : 11:54:28
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Cellectar Biosciences Inc CLRB NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,04 1,27% 3,20 11:54:28
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
3,16
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
27/3/202411:40GLOBECellectar Biosciences Reports Financial Results for Year..
20/3/202411:40GLOBECellectar Biosciences to Announce 2023 Year End Earnings..
14/3/202413:52GLOBECellectar Biosciences to Present at the 36th Annual Roth..
04/3/202412:40GLOBECellectar Biosciences Reports High Rate of Complete..
15/2/202402:31EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202422:29EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
07/2/202412:40GLOBECellectar Biosciences to Present at the Oppenheimer 34th..
02/2/202412:03EDGAR2Form 8-K - Current report
31/1/202414:00EDGAR2Form SC 13G - Statement of acquisition of beneficial..
30/1/202412:40GLOBECellectar Biosciences Announces Enrollment of the First..
25/1/202422:30EDGAR2Form 8-K - Current report
25/1/202412:40GLOBECellectar Biosciences Announces Tranche A Warrants Fully..
22/1/202412:40GLOBECellectar Biosciences Reports Complete Central Nervous..
16/1/202412:40GLOBECellectar Biosciences Broadens Pipeline with Targeted Alpha..
12/1/202412:44GLOBECellectar Biosciences to Host Conference Call with Texas..
11/1/202412:40GLOBECellectar Biosciences Partners with MiBA, a Data Subsidiary..
09/1/202412:02EDGAR2Form 8-K - Current report
08/1/202412:30GLOBECellectar Biosciences Announces Positive Topline Data..
03/1/202414:30GLOBECellectar Biosciences to Announce Top-line Data from WM..
19/12/202314:30GLOBECellectar Biosciences Expands Iopofosine I 131 Collaboration..
13/12/202302:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202302:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202302:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202302:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202314:30GLOBECellectar Biosciences Strengthens Intellectual Property..
05/12/202314:30GLOBECellectar Biosciences to Present at the Targeted..
29/11/202322:31EDGAR2Form 8-K - Current report
13/11/202312:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202312:45EDGAR2Form 8-K - Current report
31/10/202305:15EDGAR2Form EFFECT - Notice of Effectiveness
27/10/202322:40EDGAR2Form 8-K - Current report
25/10/202322:54EDGAR2Form S-3/A - Registration statement under Securities Act of..
05/10/202322:45EDGAR2Form S-3 - Registration statement under Securities Act of..
02/10/202322:40EDGAR2Form DEF 14A - Other definitive proxy statements
22/9/202322:40EDGAR2Form PRE 14A - Other preliminary proxy statements
08/9/202323:17EDGAR2Form 8-K - Current report
21/8/202322:30EDGAR2Form 8-K - Current report
14/8/202314:45EDGAR2Form 8-K - Current report
14/8/202314:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
29/6/202322:31EDGAR2Form 8-K - Current report
29/6/202312:03EDGAR2Form 8-K - Current report
29/6/202300:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/6/202300:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/6/202300:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Dernières Valeurs Consultées

NASDAQ
CLRB
Cellectar Biosciences
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés